Gene Disruption or Dysregulation in Apparently Balanced Chromosomal Rearrangements

Overview

About this study

The purpose of this study is to attempt to identify potential disruptions of genes at chromosome rearrangement breakpoints only detectable by advanced technologies and to correlate those findings with physical features found in the individuals.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals known to carry a balanced rearrangement based upon clinical studies performed at the Cytogenetics Laboratory at Mayo Clinic

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Erik Thorland, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20314167

Mayo Clinic Footer